🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Sosipatros A. Boikos

Georgetown University

ORCID: 0000-0002-8608-6962
Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Supplementary table 3 from Pharmaceutical Interference of the EWS-FLI1–driven Transcriptome By Cotargeting H3K27ac and RNA Polymerase Activity in Ewing Sarcoma

(2023)10.1158/1535-7163.22521043
Top 100%
0DataRank
Top 100%0 citations

Sheeba Jacob, Timothy L. Lochmann, Richard Kurupi, Maninderjit S. Ghotra, Marissa L. Calbert +8 more

Papers

Driven by 14 papers — median percentile 0. Top paper: “Genomic screening reveals ubiquitin-like modifier activating enzyme 1 as a potent and druggable target in c-MYC-high triple negative breast cancer models”.

Genomic screening reveals ubiquitin-like modifier activating enzyme 1 as a potent and druggable target in c-MYC-high triple negative breast cancer models

PNAS Nexus(2022)10.1093/pnasnexus/pgac232
N/A
0.482DataRank · unranked
10 citations

Tia H. Turner, Jinyang Cai, Konstantinos V. Floros, Ann K. Yu, Colin M. Coon +15 more

Embryonic stem cell factor FOXD3 (Genesis) defects in gastrointestinal stromal tumors

Endocrine Related Cancer(2023)10.1530/erc-23-0067
N/A
0.269DataRank · unranked
5 citations

Anélia Horvath, Guillaume Assié, Madson Q. Almeida, Eva Szarek, Sosipatros A. Boikos +11 more

Targeting transcription of MCL-1 sensitizes HER2-amplified breast cancers to HER2 inhibitors

Cell Death and Disease(2021)10.1038/s41419-021-03457-6
N/A
0DataRank · unranked
20 citations

Sheeba Jacob, Richard Kurupi, Carter K. Fairchild, Bin Hu, Madhavi Puchalapalli +6 more

Pharmaceutical Interference of the EWS-FLI1–driven Transcriptome By Cotargeting H3K27ac and RNA Polymerase Activity in Ewing Sarcoma

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-20-0489
N/A
0DataRank · unranked
19 citations

Sheeba Jacob, Timothy L. Lochmann, Richard Kurupi, Maninderjit S. Ghotra, Marissa L. Calbert +8 more

NCI protocol 10250: A phase II study of temozolomide and olaparib for the treatment of advanced uterine leiomyosarcoma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.11506
N/A
0DataRank · unranked
11 citations

Jacob B. Allred, Katherine Gano, Suzanne George, Steven Attia, Melissa Burgess +15 more

High-risk neuroblastoma with NF1 loss of function is targetable using SHP2 inhibition

Cell Reports(2022)10.1016/j.celrep.2022.111095
N/A
0DataRank · unranked
19 citations

Sheeba Jacob, Richard Kurupi, Krista M. Dalton, Colin M. Coon, Patricia Greninger +15 more

Genomic screening reveals UBA1 as a potent and druggable target in c-MYC-high TNBC models

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.05.17.491908
N/A
0DataRank · unranked
0 citations

Tia H. Turner, Jinyang Cai, Konstantinos V. Floros, Ann K. Yu, Colin M. Coon +15 more

Data from Adrenal Hyperplasia and Adenomas Are Associated with Inhibition of Phosphodiesterase 11A in Carriers of PDE11A Sequence Variants That Are Frequent in the Population

(2023)10.1158/0008-5472.c.6495330
N/A
0DataRank · unranked
0 citations

Christoforos Giatzakis, Audrey Robinson‐White, Sosipatros A. Boikos, Elizabeth Levine, Kurt Griffin +11 more

Data from MYCN-Amplified Neuroblastoma Is Addicted to Iron and Vulnerable to Inhibition of the System Xc-/Glutathione Axis

(2023)10.1158/0008-5472.c.6513141.v1
N/A
0DataRank · unranked
0 citations

Jinyang Cai, Sheeba Jacob, Richard Kurupi, Carter K. Fairchild, Mayuri Shende +14 more

Supplementary table 3 from Pharmaceutical Interference of the EWS-FLI1–driven Transcriptome By Cotargeting H3K27ac and RNA Polymerase Activity in Ewing Sarcoma

(2023)10.1158/1535-7163.22521043
Top 100%
0DataRank
Top 100%0 citations

Sheeba Jacob, Timothy L. Lochmann, Richard Kurupi, Maninderjit S. Ghotra, Marissa L. Calbert +8 more

Targeting of SUMOylation leads to cBAF complex stabilization and disruption of the SS18::SSX transcriptome in Synovial Sarcoma

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.04.25.591023
N/A
0DataRank · unranked
0 citations

Carter K. Fairchild, Jinxiu Li, Kun Zhang, Jane L. Roberts, Richard Kurupi +34 more

NCI protocol 10250: A phase II study of temozolomide and olaparib for the treatment of advanced uterine leiomyosarcoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps11570
N/A
0DataRank · unranked
6 citations

Jacob B. Allred, Katherine Gano, Suzanne George, Steven Attia, Melissa Burgess +8 more

Targeting SUMOylation promotes cBAF complex stabilization and disruption of the SS18::SSX transcriptome in synovial sarcoma

Nature Communications(2025)10.1038/s41467-025-64665-8
N/A
0DataRank · unranked
8 citations

Carter K. Fairchild, Jinxiu Li, Kun Zhang, Jane L. Roberts, Richard Kurupi +42 more

MYCN -Amplified Neuroblastoma Is Addicted to Iron and Vulnerable to Inhibition of the System Xc-/Glutathione Axis

Cancer Research(2021)10.1158/0008-5472.can-20-1641
N/A
0DataRank · unranked
155 citations

Jinyang Cai, Sheeba Jacob, Richard Kurupi, Carter K. Fairchild, Mayuri Shende +14 more